# CAPECITABINE
> **ANDA210203** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2024-03-05
## Drug
- **FDA Application Number:** ANDA210203
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CAPECITABINE
- **Generic name:** CAPECITABINE
- **Active ingredients:** CAPECITABINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 2024-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210203)
---
*AI Analytics · CC0 1.0*